Application Nr Approved Date Route Status External Links
ANDA091689 None Oral None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Rivastigmine Tartrate Capsules Are An Acetylcholinesterase Inhibitor Indicated For Treatment Of: Mild-To-Moderate Dementia Of The Alzheimer’s Type (ad) (1.1) Mild-To-Moderate Dementia Associated With Parkinson’s Disease (pd) (1.2) 1.1 Alzheimer’s Disease Rivastigmine Tartrate Capsules Are Indicated For The Treatment Of Mild-To-Moderate Dementia Of The Alzheimer's Type (ad). 1.2 Parkinson’s Disease Dementia Rivastigmine Tartrate Capsules Are Indicated For The Treatment Of Mild-To-Moderate Dementia Associated With Parkinson’s Disease (pd).

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Rivastigmine Tartrate RIVASTIGMINE TARTRATE ZINC895301

Comments